pool adsSpdr S&p Pharmaceuticals $XPH Technical Update
The Spdr S&p Pharmaceuticals (NYSE: XPH) update and the technical summary table below can help you manage risk and optimize returns. We have day, swing, and longer-term trading plans for XPH, and 1300 other stocks too, updated in real time for our trial subscribers. The data below is a snapshot, but updates are available now.
Technical Summary
| Term → | Near | Mid | Long |
|---|---|---|---|
| Rating | Weak | Neutral | Neutral |
| P1 | 42.32 | 40.53 | 42.64 |
| P2 | 43.22 | 42.94 | 47.43 |
| P3 | 44.04 | 45.05 | 51.98 |
Support and Resistance Plot Chart for XPH
Long Term Trading Plans for XPH
November 17, 2018, 7:15 pm ET
The Technical Summary and Trading Plans for XPH help you determine where to buy, sell, and set risk controls. The data is best used in conjunction with our Market Analysis and Stock Correlation Filters too, because those help us go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis with this XPH Report.
XPH - (Long) Support Plan
Buy over 42.64 target 47.43 stop loss @ 42.38.
The technical summary data tells us to buy XPH near 42.64 with an upside target of 47.43. This data also tells us to set a stop loss @ 42.38 to protect against excessive loss in case the stock begins to move against the trade. 42.64 is the first level of support below 43.39 , and by rule, any test of support is a buy signal. In this case, support 42.64 would be being tested, so a buy signal would exist.
XPH - (Short) Resistance Plan
Short under 47.43 target 42.64 stop loss @ 47.69.
The technical summary data is suggesting a short of XPH as it gets near 47.43 with a downside target of 42.64. We should have a stop loss in place at 47.69 though. 47.43 is the first level of resistance above 43.39, and by rule, any test of resistance is a short signal. In this case, if resistance 47.43 is being tested, so a short signal would exist.
